Revelation Biosciences faces $7.3M judgment in LifeSci Capital lawsuit

REVELATION BIOSCIENCES, INC.

U.S. District Court entered summary judgment against Revelation Biosciences for ~$7.3M in unpaid banking and advisory fees plus interest.
Judgment adopted Magistrate Judge's December 2023 recommendation; company had contested fee obligation from pre-merger contracts.
Company states it has sufficient cash to satisfy the judgment and expects no immediate impact on clinical trial programs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.